The Supreme Court has recently taken an increased interest in patent cases. In recent months the Supreme Court has granted certiorari on a trilogy of patent cases:
A Word from the Editor: Are the Patent Laws About to Change?
The Supreme Court has recently taken an increased interest in patent cases. In recent months the Supreme Court has granted certiorari on a trilogy of patent cases: <i>Medimmune, Inc. v. Genentech, Inc.</i>, case number 05-608, on Feb. 21, 2006 (<i>www.supreme courtus.gov/docket/05-608.htm</i>); <i>Ebay, Inc. v. MercExchange, L.L.C.</i>, case number 05-130, on Nov. 28, 2005 (<i>www.supremecourtus.gov/docket/05-130.htm</i>) and <i>Lab Corp. of Am. Holdings v. Metabolite Labs, Inc.</i>, case number 04-607, on Oct. 31, 2005 (<i>www.supremecourtus.gov/docket/04-607.htm</i>). Collectively, the decisions in these cases could reshape the patent landscape: addressing the right of licensees to challenge patents, the ability of patent holders to secure injunctions and the breadth of business method patents. More specifically, the questions before the Court in the three cases are set forth below.
This premium content is locked for LawJournalNewsletters subscribers only
ENJOY UNLIMITED ACCESS TO THE SINGLE SOURCE OF OBJECTIVE LEGAL ANALYSIS, PRACTICAL INSIGHTS, AND NEWS IN LawJournalNewsletters
- Stay current on the latest information, rulings, regulations, and trends
- Includes practical, must-have information on copyrights, royalties, AI, and more
- Tap into expert guidance from top entertainment lawyers and experts
Already have an account? Sign In Now
For enterprise-wide or corporate access, please contact Customer Service at [email protected] or call 1-877-256-2473.






